113 related articles for article (PubMed ID: 21295523)
41. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
Bhojwani D; Kang H; Moskowitz NP; Min DJ; Lee H; Potter JW; Davidson G; Willman CL; Borowitz MJ; Belitskaya-Levy I; Hunger SP; Raetz EA; Carroll WL
Blood; 2006 Jul; 108(2):711-7. PubMed ID: 16822902
[TBL] [Abstract][Full Text] [Related]
42. Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.
Samuels AL; Peeva VK; Papa RA; Firth MJ; Francis RW; Beesley AH; Lock RB; Kees UR
BMC Genomics; 2010 Apr; 11():256. PubMed ID: 20406497
[TBL] [Abstract][Full Text] [Related]
43. Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2013 Feb; 42(2):741-8. PubMed ID: 23232667
[TBL] [Abstract][Full Text] [Related]
44. Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance.
Hoff FW; Hu CW; Qiu Y; Ligeralde A; Yoo SY; Scheurer ME; de Bont ESJM; Qutub AA; Kornblau SM; Horton TM
Mol Cancer Res; 2018 Aug; 16(8):1263-1274. PubMed ID: 29669823
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2012 Apr; 40(4):1277-84. PubMed ID: 22200740
[TBL] [Abstract][Full Text] [Related]
46. Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.
Sheard MA; Ghent MV; Cabral DJ; Lee JC; Khankaldyyan V; Ji L; Wu SQ; Kang MH; Sposto R; Asgharzadeh S; Reynolds CP
Exp Cell Res; 2015 May; 334(1):78-89. PubMed ID: 25845499
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.
Barrett DM; Seif AE; Carpenito C; Teachey DT; Fish JD; June CH; Grupp SA; Reid GS
Blood; 2011 Oct; 118(15):e112-7. PubMed ID: 21856863
[TBL] [Abstract][Full Text] [Related]
48. Pathway analysis of microarray data via regression.
Adewale AJ; Dinu I; Potter JD; Liu Q; Yasui Y
J Comput Biol; 2008 Apr; 15(3):269-77. PubMed ID: 18331198
[TBL] [Abstract][Full Text] [Related]
49. Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling.
Queudeville M; Seyfried F; Eckhoff SM; Trentin L; Ulrich S; Schirmer M; Debatin KM; Meyer LH
Cell Death Dis; 2012 Aug; 3(8):e364. PubMed ID: 22875001
[TBL] [Abstract][Full Text] [Related]
50. Diversity of human leukemia xenograft mouse models: implications for disease biology.
Meyer LH; Debatin KM
Cancer Res; 2011 Dec; 71(23):7141-4. PubMed ID: 22088964
[TBL] [Abstract][Full Text] [Related]
51. Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
Roberts KG; Mullighan CG
Nat Rev Clin Oncol; 2015 Jun; 12(6):344-57. PubMed ID: 25781572
[TBL] [Abstract][Full Text] [Related]
52. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
Irving J; Matheson E; Minto L; Blair H; Case M; Halsey C; Swidenbank I; Ponthan F; Kirschner-Schwabe R; Groeneveld-Krentz S; Hof J; Allan J; Harrison C; Vormoor J; von Stackelberg A; Eckert C
Blood; 2014 Nov; 124(23):3420-30. PubMed ID: 25253770
[TBL] [Abstract][Full Text] [Related]
53. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
Samuels AL; Beesley AH; Yadav BD; Papa RA; Sutton R; Anderson D; Marshall GM; Cole CH; Kees UR; Lock RB
Blood Cancer J; 2014 Aug; 4(8):e232. PubMed ID: 25083816
[TBL] [Abstract][Full Text] [Related]
54. Stem cell gene expression programs influence clinical outcome in human leukemia.
Eppert K; Takenaka K; Lechman ER; Waldron L; Nilsson B; van Galen P; Metzeler KH; Poeppl A; Ling V; Beyene J; Canty AJ; Danska JS; Bohlander SK; Buske C; Minden MD; Golub TR; Jurisica I; Ebert BL; Dick JE
Nat Med; 2011 Aug; 17(9):1086-93. PubMed ID: 21873988
[TBL] [Abstract][Full Text] [Related]
55. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C
Nature; 2019 Aug; 572(7768):254-259. PubMed ID: 31316209
[TBL] [Abstract][Full Text] [Related]
56. Evolutionary determinants of curability in cancer.
Mansur MB; deSouza NM; Natrajan R; Abegglen LM; Schiffman JD; Greaves M
Nat Ecol Evol; 2023 Nov; 7(11):1761-1770. PubMed ID: 37620552
[TBL] [Abstract][Full Text] [Related]
57. Application status and future prospects of the PDX model in lung cancer.
Liu W; Cui Y; Zheng X; Yu K; Sun G
Front Oncol; 2023; 13():1098581. PubMed ID: 37035154
[TBL] [Abstract][Full Text] [Related]
58. The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer.
Aloliqi AA; Fararjeh AF; Al-Khader A; Kaddumi E; Eisa AA; Jaradat W
World J Oncol; 2023 Feb; 14(1):84-93. PubMed ID: 36895992
[TBL] [Abstract][Full Text] [Related]
59. Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion.
Dal Molin A; Tretti Parenzan C; Gaffo E; Borin C; Boldrin E; Meyer LH; Te Kronnie G; Bresolin S; Bortoluzzi S
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36585787
[TBL] [Abstract][Full Text] [Related]
60. In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Wirth AK; Wange L; Vosberg S; Henrich KO; Rausch C; Özdemir E; Zeller CM; Richter D; Feuchtinger T; Kaller M; Hermeking H; Greif PA; Senft D; Jurinovic V; Bahrami E; Jayavelu AK; Westermann F; Mann M; Enard W; Herold T; Jeremias I
Leukemia; 2022 Dec; 36(12):2863-2874. PubMed ID: 36333584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
